("REL" or the "Company")
Notice of Annual General Meeting
The Company announces that its Annual General Meeting ("AGM") will be held at, Trafalgar Court, Les Banques,
The Board of Directors of the Company notes the potential impact of the COVID-19 pandemic on the AGM and considers the well-being of Shareholders and other AGM attendees as a priority.
If the restrictions on travel introduced by the States of
Whilst restrictions in the Bailiwick of
All Shareholders are urged to submit Forms of Proxy in respect of the AGM to ensure their vote is registered. Shareholders should complete and sign the Form of Proxy accompanying the Notice of AGM in accordance with the instructions printed on the Form of Proxy.
The Company will continue to monitor developments, including any regulatory changes as the situation in relation to COVID-19 continues. If it becomes necessary or appropriate to revise the arrangements for the AGM, further announcements will be made and information will be made available on our website at: http://www.RiverstoneREL.com/investors/reports-and-presentations/.
The Notice of AGM and Form of Proxy have been dispatched to all Shareholders. An electronic copy of the Notice of AGM and Form of Proxy are also available on the Company's website http://www.RiverstoneREL.com/investors/reports-and-presentations/.
A copy of the Notice and Form of Proxy can be inspected at the National Storage Mechanism website at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
- ENDS -
About
REL is a closed-ended investment company that invests exclusively in the global energy industry across all sectors. REL aims to capitalise on the opportunities presented by Riverstone's energy investment platform. REL's ordinary shares are listed on the
For further details, see www.RiverstoneREL.comm
Neither the contents of
Media Contacts
For
+44 20 3206 6300
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the